Evidence map›Paper›PMID 38424361›Full record

ArticleCommunications biology2024

Author Correction: Antagonistic interactions safeguard mitotic propagation of genetic and epigenetic information in zebrafish.

Divine-Fondzenyuy Lawir, Cristian Soza-Ried, Norimasa Iwanami, Iliana Siamishi, Göran O Bylund, Connor O Meara, Katarzyna Sikora, Benoît Kanzler, Erik Johansson, Michael Schorpp and 2 more

Abstract readPublished Erratum
In one paragraph

Article in Communications biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Divine-Fondzenyuy LawirDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Cristian Soza-RiedDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0001-9490-4083
Norimasa IwanamiDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Iliana SiamishiDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Göran O BylundDepartment of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.
Connor O MearaDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Katarzyna SikoraDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-4523-3524
Benoît KanzlerTransgenic Mouse Core Facility, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
Erik JohanssonDepartment of Medical Biochemistry and Biophysics, Umeå University, Umeå, Sweden.ORCID http://orcid.org/0000-0002-8526-6224
Michael SchorppDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0003-2067-2480
Pierre CauchyDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.ORCID http://orcid.org/0000-0002-0659-0799
Thomas BoehmDepartment of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany. boehm@ie-freiburg.mpg.de.ORCID http://orcid.org/0000-0001-5172-7478

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38424361
PMCPMC10904371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.